Newsroom

Emmes is excited to share the significant progress being made in clinical studies.

 We also give you a look inside some of our own news.

 

 

Emmes Newsroom
Company News
Emmes Supports Groundbreaking Anal Cancer Study Sponsored by the National Cancer Institute

Read more Download

Emmes Newsroom
Company News
Emmes Supports Landmark mRNA COVID-19 Vaccine Trial in Sub-Saharan Africa

Read more Download

Emmes Newsroom
Company News
Emmes launches Advantage eClinical as a standalone cloud native clinical technology platform

Read more Download

Emmes Newsroom
Company News
Emmes and Casimir Announce Research About a Novel, Home-Based Assessment for Duchenne Muscular Dystrophy

Read more Download

Emmes Newsroom
Company News
Emmes Acquires Casimir, Its Fourth Major Acquisition

Read more Download

Emmes Newsroom
Company News
Emmes Supports New Collaboration to Accelerate COVID-19 Research for Children

Read more Download

Emmes Newsroom
Company News
Emmes Acquires Institut Dr. Schauerte, Entering Real World Evidence Market

Read more Download

Emmes Newsroom
Company News
Emmes Announces Completion of Third ACTT Clinical Trial for COVID-19

Read more Download

Emmes Newsroom
Company News
Emmes and MedGenome Launch Genomics Strategic Partnership Focused on Advancing Rare Disease Research

Read more Download

Emmes Newsroom
Company News
Emmes launches Orphan Reach™: Emmes’ Rare Disease Center

Read more Download